Cubist Systematic Strategies’s Abiomed Inc ABMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-27,944
Closed -$6.87M 4853
2022
Q3
$6.87M Sell
27,944
-5,386
-16% -$1.45M 0.04% 779
2022
Q2
$8.25M Buy
33,330
+17,903
+116% +$4.83M 0.05% 578
2022
Q1
$5.11M Buy
+15,427
New +$4.75M 0.04% 717
2021
Q4
Sell
-8,154
Closed -$2.65M 3719
2021
Q3
$2.65M Sell
8,154
-9,126
-53% -$3.09M 0.03% 827
2021
Q2
$5.39M Buy
17,280
+12,871
+292% +$3.95M 0.06% 494
2021
Q1
$1.41M Buy
4,409
+913
+26% +$292K 0.02% 1295
2020
Q4
$1.13M Sell
3,496
-4,162
-54% -$1.15M 0.02% 1308
2020
Q3
$2.12M Sell
7,658
-1,699
-18% -$489K 0.03% 862
2020
Q2
$2.26M Buy
+9,357
New +$1.88M 0.04% 711
2020
Q1
Sell
-36,651
Closed -$6.25M 2570
2019
Q4
$6.25M Buy
36,651
+30,325
+479% +$5.62M 0.11% 219
2019
Q3
$1.13M Sell
6,326
-21,496
-77% -$4.65M 0.02% 928
2019
Q2
$7.25M Buy
27,822
+587
+2% +$156K 0.13% 184
2019
Q1
$7.78M Buy
27,235
+26,490
+3,556% +$8.8M 0.25% 53
2018
Q4
$242K Sell
745
-28,216
-97% -$9.8M 0.01% 1413
2018
Q3
$13M Sell
28,961
-197
-0.7% -$77.7K 0.71% 8
2018
Q2
$11.9M Buy
29,158
+12,358
+74% +$4.48M 0.6% 3
2018
Q1
$4.89M Buy
16,800
+747
+5% +$189K 0.29% 51
2017
Q4
$3.01M Buy
16,053
+10,708
+200% +$2M 0.16% 119
2017
Q3
$901K Buy
5,345
+1,763
+49% +$267K 0.05% 487
2017
Q2
$513K Buy
3,582
+489
+16% +$65.7K 0.03% 732
2017
Q1
$387K Buy
3,093
+2,593
+519% +$301K 0.03% 772
2016
Q4
$56K Sell
500
-5,728
-92% -$664K ﹤0.01% 1569
2016
Q3
$801K Sell
6,228
-55,901
-90% -$6.7M 0.05% 504
2016
Q2
$6.79M Buy
+62,129
New +$6.18M 0.39% 23
2016
Q1
Sell
-7,941
Closed -$717K 1900
2015
Q4
$717K Sell
7,941
-4,579
-37% -$389K 0.04% 638
2015
Q3
$1.16M Sell
12,520
-8,480
-40% -$747K 0.06% 491
2015
Q2
$1.38M Buy
21,000
+17,398
+483% +$1.16M 0.07% 409
2015
Q1
$258K Buy
+3,602
New +$196K 0.01% 1361

Other funds holding ABMD